KPNA2 and osteosarcoma: Three of 4 (75%) telangiectatic and two of 3 (66.7%) giant cell-rich osteosarcoma samples had positive KPNA2 staining, with 50 and 33.3% of samples showing strong-intensity staining, respectively (Fig. 3 g-j).